Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

With METROPOLIS's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.

Financial Ratios:

currentRatio 1.175000
forwardPE 35.284332
debtToEquity 15.295000
earningsGrowth -0.196000
revenueGrowth 0.043000
grossMargins 0.798160
operatingMargins 0.097520
trailingEps 28.100000
forwardEps 0.000000

METROPOLIS's current ratio of 1.175 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, METROPOLIS can comfortably cover its liabilities, reflecting a strong financial outlook.
METROPOLIS's low Debt-to-Equity ratio signals the company is not over-leveraged, meaning it has a conservative approach to debt. This reduces financial risk and indicates a stable financial foundation, providing flexibility and security, which can appeal to investors seeking lower-risk investments.
METROPOLIS's low growth in earnings and revenue indicates a potential decline in profits. This suggests that the company could be facing financial challenges, making it harder to sustain its current profit margins.
Metropolis Healthcare Limited's negative gross and operating margins indicate that the company is currently unprofitable at both the production and operational levels. This suggests significant challenges in managing costs and generating revenue, which could impact its overall financial health.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

Over time, METROPOLIS's price projections have been gradually lowered, signaling declining confidence in the company's future outlook. The downward revisions suggest analysts are becoming more cautious about METROPOLIS's potential for growth.

Insider Transactions:

Insider Transactions for METROPOLIS
Insider Transactions for METROPOLIS


METROPOLIS experienced 2 selling transactions, with market price of 2095.9249267578125.The period under consideration saw no sell transactions.The recent buying activity at current METROPOLIS price levels exceeds selling, suggesting a potential positive outlook. Investors may see this trend as an indicator that the stock is likely to perform well, reflecting growing confidence.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


Analysts' recent buy bias toward Metropolis Healthcare Limited suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see Metropolis Healthcare Limited as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.